Alzheimer's Disease

Nearly 44 million people have Alzheimer’s or a related dementia worldwide, according to the Alzheimer’s Disease International　organization. That number is expected to double every 20 years. Unlike other books on the market,　Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy　covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer’s and other forms of dementia. First, readers are introduced to the cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to symptoms and the quality of life in Alzheimer’s disease. In addition, some chapters discuss recent studies on memory dysfunction in advanced-stage Alzheimer’s disease, in comparison to early-stage Alzheimer’s disease, including a chapter on the factors underlying transition from mild cognitive impairment to Alzheimer’s disease.　 Following this section, some chapters present recent studies on the role of different cortical and subcortical structures in the development of different symptoms in Alzheimer’s disease as well as different neural biomarkers underlying the development and treatment of Alzheimer’s disease. In the last section of the book, therapeutic aspects of Alzheimer’s disease, focusing on behavioral and pharmacological treatments of sleep disorders, memory problems, and depression, in Alzheimer’s disease are reviewed.　Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy　aid readers with keeping up with the advances in research and care making it a prime tool for clinicians, psychologists, researcher, neurologists, and caregivers of dementia patients.　

• Reviews recent developments of cognitive and clinical studies
• Covers factors underlying transition from mild cognitive impairment to Alzheimer's disease
• Discusses different neural biomarkers underlying the development and treatment of Alzheimer's disease
• Provides a comparison on the effectiveness of various types of treatments

Advanced students and researchers in cognitive and behavioral neuroscience, psychology, psychiatry, psychotherapy, neurology

1. The types of memory dysfunction in Alzheimer’s disease
   2. The prevalence of Depression in Alzheimer’s disease
   3. Quality of life in Alzheimer’s disease
   4. Cognitive and memory dysfunction in advanced-stage Alzheimer’s disease
   5. Past and future thinking processes in Alzheimer’s disease
   6. Factors underlying the transition from mild cognitive impairment to Alzheimer’s disease
   7. Understanding the complexity and subtypes of Alzheimer’s disease
   8. Different neural abnormalities in Alzheimer’s disease: dissociating the role of cortical and subcortical structures
   9. Recent studies of behavioral and neural markers of different symptoms in Alzheimer’s disease
   10. Enhancing autobiographical memory in Alzheimer’s disease
   11. Cognitive training and mindlessness for the treatment of Alzheimer’s disease
   12. The treatment of sleep disorders in Alzheimer’s disease
   13. Pharmacological treatment for Alzheimer’ disease: recent advancement
   14. The role of exercise and nutrition in the treatment of Alzheimer’s disease